TOKENPOST
1 min read
Add as a preferred source on Google

Scinai Immunotherapeutics Ltd. Posts 167% Revenue Growth Through September

The company’s net loss was $390,000, compared with $6.24 million in the year-earlier period.

By John Kim
Published
An open earnings booklet beside rising glass forms on a warm plinth / TokenPost.ai
An open earnings booklet beside rising glass forms on a warm plinth / TokenPost.ai

Scinai Immunotherapeutics Ltd. generated $2.80 million in revenue over the nine months through Sept. 30, 2026, a 167% increase from the same period in 2025.

Its net loss for the period was $390,000, down from $6.24 million in the first nine months of 2025.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…